20045 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Pulmonary tract; Aromatherapy; Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient
#2LOW DOSE THERAPEUTIC TREATMENT
#3METERED DOSE INHALERS AND SUSPENSION COMPOSITIONS
#4Therapeutic Formulation
#5PRODUCTION OF RECOMBINANT LUBRICIN
#6METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOF
#7INHALATION FORMULATION FOR TREATING IPF DISEASE AND PREPARATION METHOD THEREFOR
#8METERED DOSE INHALER FOR IPRATROPIUM BROMIDE SOLUTION
#9IPRATROPIUM DELIVERY COMPOSITIONS, DEVICES AND METHODS
#10PRESSURIZED INHALATION COMPOSITION OF TIOTROPIUM
#11EUTECTIC SOLVENTS COMPRISING PHARMACEUTICAL AGENTS, AND METHODS OF MAKING AND USE THEREOF
#12A PHARMACEUTICAL COMPOSITION OF SALBUTAMOL AND PHARMACEUTICAL GREEN PROPELLANT
#13COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#14LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#15COMPOSITIONS, DEVICES AND METHODS FOR RESPRITORY DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS
#16PHARMACEUTICAL COMPOSITION COMPRISING SALBUTAMOL
#17INHALABLE COMPOSITION FOR ENHANCING ALERTNESS AND VITALITY AND DEVICE FOR SUPPLYING THE INHALABLE COMPOSITION
#18COMBINATION OF ALBUTEROL AND BUDESONIDE FOR THE TREATMENT OF ASTHMA
#19GUEST/HOST INCLUSION COMPLEXES CONTAINING S-NITROSOGLUTATHIONE AND METHODS OF USE THEREOF
#20A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER
#21A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER
#22COMPOSITION FOR USE IN PRESSURISED DISPENSING CONTAINER
#23ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
#24Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders
#25AEROSOL FORMULATION FOR COPD
#26Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient
#27MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS
#28METHODS OF TREATING OR PREVENTING RESPIRATORY DISEASE WITH HOUTTUYNIA CORDATA THUNB-BASED AEROSOL INHALATION THERAPY
#29METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER LUNG DISORDERS
#30Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods Comprising Them
#31NICOTINE FORMULATION
#32SALBUTAMOL DELIVERY COMPOSITIONS, DEVICES AND METHODS
#33Fumaric Acid Esters, Inhalation Administration Methods, Pharmaceutical Uses and Compositions
#34COMPOSITIONS AND METHODS OF MAKING BRITTLE-MATRIX PARTICLES THROUGH BLISTER PACK FREEZING
#35INHALABLE FORMULATIONS
#36DITHIOLSACCHARIDE MUCOLYTIC AGENTS AND USES THEREOF
#37DITHIOLSACCHARIDE MUCOLYTIC AGENTS AND USES THEREOF
#38INHALED IMATINIB FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)
#39N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
#40COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
#41METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOF
#42PHARMACEUTICAL COMPOSITIONS COMPRISING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION
#43PHARMACEUTICAL COMPOSITION COMPRISING SALBUTAMOL
#44METHODS AND COMPOSITIONS FOR TREATING MUCOSAL TISSUE DISORDERS
#45SALBUTAMOL DELIVERY FORMULATIONS, DEVICES AND METHODS
#46GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS
#47PROPELLANTS FOR ANTICHOLINERGIC AGENTS IN PRESSURIZED METERED DOSE INHALERS
#48COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS
#49GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS
#50AEROSOL DELIVERY OF PIRFENIDONE
#51SUBSTITUTED PYRIDINES AND PYRIDAZINES AS TYK2 INHIBITORS
#52SUBSTITUTED PYRIDINES, PYRIDAZINES, AND PYRIMIDINES AS TYK2 INHIBITORS
#53METERED DOSE INHALERS AND SOLUTION COMPOSITIONS
#54ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
#55INHALANT CANNABIDIOL (CBD) IN THE TREATMENT OF GLIOBLASTOMA
#56COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
#57TREATMENT OF RESPIRATORY CONDITIONS
#58FORMULATIONS FOR THE TREATMENT OF RESPIRATORY DISORDERS
#59COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
#60AEROSOL AND TOPICAL ADMINISTRATION OF A FORMULATION CONTAINING CYCLODEXTRIN, QUERCETIN AND ZINC, IN COMBINATION OR SEPARATELY, TO MITIGATE INFECTION BY ENVELOPED VIRUSES
#61MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION
#62MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION
#63Delivery Of Esketamine For The Treatment Of Depression
#64TARGETED DELIVERY OF EFFECTIVE THERAPEUTIC MEDICATIONS TO THE RESPIRATORY TRACT
#65REPEATED ADMINISTRATION OF DIHYDROERGOTAMINE FOR TREATMENT OF FREQUENT MIGRAINE HEADACHES
#66COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
#67COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
#68PHARMACEUTICAL FORMULATIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOF
#69PHARMACEUTICAL AEROSOL PRODUCT FOR ADMINISTRATION BY ORAL OR NASAL INHALATION
#70FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION
#714'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO
#72INHALABLE COMPOSITION OF CLOFAZIMINE AND METHODS OF USE THEREOF
#73EUTECTIC SOLVENTS COMPRISING PHARMACEUTICAL AGENTS, AND METHODS OF MAKING AND USE THEREOF
#74STABLE LIQUID PHARMACEUTICAL COMPOSITION CONTAINING KUDING SAPONIN COMPOUND
#75LOCALIZED THERAPY OF LOWER AIRWAYS INFLAMMATORY DISORDERS WITH PROINFLAMMATORY CYTOKINE INHIBITORS
#76PROCASPASE COMBINATION THERAPY FOR GLIOBLASTOMA
#77PHARMACEUTICAL COMPOSITION
#78PHARMACEUTICAL COMPOSITION
#79LOW DOSE THERAPEUTIC TREATMENT
#80EMOLLIENT TOPICAL DISINFECTANTS
#81COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
#82Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods Comprising Them
#83SUBSTITUTED PYRIMIDINES AND METHODS OF USE
#84COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#85METHODS FOR DELIVERY OF PSYCHEDELIC MEDICATIONS BY INHALATION AND SYSTEMS FOR PERFORMING THE METHODS
#86PRESSURED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION
#87Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors
#88Eye-soothing Externally-applied Liquid Medicine and Preparation Method Therefor
#89MAGNETIC RESONANCE SPECTROSCOPY TO CALIBRATE AND SELECT DOSES, FORMULATIONS, AND DEVICES FOR INTRA-NASAL ADMINISTRATION OF N-ACETYLCYSTEINE
#90CONFORMAL COATING OF CELLS FOR IMMUNOISOLATION
#91A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER
#92PHARMACEUTICAL COMPOSITION
#93PRODUCTION OF RECOMBINANT LUBRICIN
#94ANTI-INFECTION AND ANTI-TUMOR MUCOSAL IMMUNE PREPARATION
#95METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE
#96Substituted pyridines and pyridazines as TYK2 inhibitors
#97Substituted pyridines, pyridazines, and pyrimidines as TYK2 inhibitors
#98AEROSOLIZED HYALURONIDASE AND/OR 4-METHYLUMBELLIFERONE COMPOSITIONS AND METHODS OF USING SAME TO TREAT RESPIRATORY DISEASES OR DISORDERS
#99METHODS AND COMPOSITIONS FOR TREATING AND COMBATTING TUBERCULOSIS
#100MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS
#101AEROSOL FORMULATION FOR COPD
#102TREATMENTS
#103Niraparib particles and uses thereof
#104LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#105NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#106ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
#107HUMAN ANTI-INFLAMMATORY PEPTIDES FOR THE INHALATORY TREATMENT OF INFLAMMATORY PULMONARY ISSUES
#108UNIT DOSES, AEROSOLS, KITS, AND METHODS FOR TREATING HEART CONDITIONS BY PULMONARY ADMINISTRATION
#109Aerosol and topical administration of a formulation containing cyclodextrin, quercetin and zinc, in combination or separately, to mitigate infection by enveloped viruses
#110INHALER
#111Aerosolized Formulations of HIV Protease Inhibitors for the Treatment of Airway Reflux
#112TREPROSTINIL ADMINISTRATION BY INHALATION
#113MEDICINAL COMPOSITIONS FOR CARBON DIOXIDE BASED METERED DOSE INHALERS
#114PHARMACEUTICAL COMPOSITION
#115PHOSPHATE DERIVATIVES OF RORGAMMA MODULATORS AND USES THEREOF
#116CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINES
#117PHARMACEUTICAL COMPOSITION
#118PHARMACEUTICAL COMPOSITION
#119COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY
#120METHODS AND COMPOSITIONS FOR TREATING SEIZURE DISORDERS IN PEDIATRIC PATIENTS
#121STAINLESS STEEL CAN FOR PRESSURISED METERED DOSE INHALERS
#122NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF
#123METHODS, COMPOSITIONS, AND VACCINES FOR TREATING A VIRUS INFECTION
#124DRY POWDER FORMULATIONS OF TAMIBAROTENE FOR PULMONARY AND INTRANASAL DELIVERY
#125Substituted pyrimidines and methods of use
#126METHODS AND COMPOSITIONS FOR GENERATING NITRIC OXIDE AND USES THEREOF
#127Targeted therapy for treatment of chronic rhinosinusitis
#128Medicament for prevention or treatment of rhinovirus infection
#129AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE
#130Compositions and methods of making brittle-matrix particles through blister pack freezing
#131METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS AND REDUCING CANDIDIASIS
#132Methods and compositions for treatment of pulmonary hypertension and other lung disorders
#133PALONOSETRON FORMULATIONS AND USES THEREOF
#134INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CYCLOBENZAPRINE
#135DEVICE, METHODS AND USES FOR TREATING ANAPHYLAXIS
#136TREPROSTINIL ADMINISTRATION BY INHALATION
#137METERED DOSING COMPOSITIONS AND METHODS OF USE OF PSYCHEDELIC COMPOUNDS
#138ORONASAL CBD FORMULATIONS AND USES THEREOF
#139Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
#140METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOF
#141AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE
#142USE OF CICLESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES
#143ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
#144TREPROSTINIL ADMINISTRATION BY INHALATION
#145ANTIARRHYTHMIC FORMULATION
#146SPECIAL HEPARINOID COMPOSITION, WITH REPAIR, PROPHYLACTIC AND ANTI-INFLAMMATORY EFFECTS, APPLIED TO THE LUNGS
#147Pharmaceutical composition
#148COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS
#149COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS
#150METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND PULMONARY ARTERIAL HYPERTENSION
#151Compounds and pharmaceutical uses thereof
#152Methods and compositions for treating mucosal tissue disorders
#153Lipo-glycopeptide cleavable derivatives and uses thereof
#154PHARMACEUTICAL COMPOSITION
#155Conformal coating of cells for immunoisolation
#156ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
#157PRESSURIZED METERED DOSE INHALERS AND METHOD OF MANUFACTURE
#158DELIVERY OF AEROSOLIZED MICROMOLAR COMPOSITION CONCENTRATIONS
#159AEROSOL TYROSINE KINASE INHIBITOR COMPOUNDS AND USES THEREOF
#160Methods and compositions for treatment of pulmonary hypertension and other lung disorders
#161Administration of benzodiazepine compositions
#162Compounds and pharmaceutical uses thereof
#163FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION
#164DRY POWDER COMPOSITIONS WITH MAGNESIUM STEARATE
#165Treprostinil administration by inhalation
#166Methods of treatment using a JAK inhibitor compound
#167COMPOUND DELIVERY SYSTEMS AND METHODS OF PRODUCTION
#168STABILIZED TERPENE-ENRICHED CANNABINOID EXTRACT AND METHODS OF USE THEREOF
#169Pharmaceutical composition
#170COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS
#171Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#172UMECLIDINIUM AND VILANTEROL FORMULATION AND INHALER
#173ORONASAL CBD FORMULATIONS AND USES THEREOF
#174CRYSTALLINE ALK5 INHIBITORS AND USES THEREOF
#175PHARMACEUTICAL FORMULATION CONTAINING GLYCOPYRROLATE AND INDACATEROL MALEATE
#176PHARMACEUTICAL COMPOSITION
#177Inhalable powder formulations of alginate oligomers
#178PHARMACEUTICAL COMPOSITIONS COMPRISING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION
#179Pharmaceutical composition
#180Pharmaceutical composition
#181Pharmaceutical composition
#1824'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO
#183Pharmaceutical Compositions
#184EUTECTIC SOLVENTS COMPRISING PHARMACEUTICAL AGENTS, AND METHODS OF MAKING AND USE THEREOF
#185Administration of benzodiazepine compositions
#186Procaspase combination therapy for glioblastoma
#187Method for treatment of a viral-mediated infectious disease
#188TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS
#189FLUTICASONE AND VILANTEROL FORMULATION AND INHALER
#190Pharmaceutical aerosol product for administration by oral or nasal inhalation
#191COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
#192Tiotropium formulation and inhaler
#193N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
#194APPARATUS FOR USE IN DELIVERING RESPIRATORY DRUGS
#195PHARMACEUTICAL COMPOSITION COMPRISING SALBUTAMOL
#196REPEATED ADMINISTRATION OF DIHYDROERGOTAMINE FOR TREATMENT OF FREQUENT MIGRAINE HEADACHES
#197Dithiolsaccharide mucolytic agents and uses thereof
#198Methods and compositions for treatment of pulmonary hypertension and other lung disorders
#199Delivery of esketamine for the treatment of depression
#200COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS
#201COMPOSITION FOR TREATING A PATIENT WITH A RESPIRATORY DISEASE CAUSED BY CHRONIC INFLAMMATION, PRODUCTION METHOD, AND USE OF SAID COMPOSITION
#202FLUTICASONE AND VILANTEROL FORMULATION AND INHALER
#203Aerosol delivery of pirfenidone
#204Production of recombinant lubricin
#205Procaspase 3 activation by combination therapy
#206USE OF MAGNETIC RESONANCE SPECTROSCOPY TO CALIBRATE AND SELECT DOSES, FORMULATIONS, AND DEVICES FOR INTRA-NASAL ADMINISTRATION OF N-ACETYLCYSTEINE
#207PALONOSETRON FORMULATIONS AND USES THEREOF
#208Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders
#209Inhaled imatinib for treatment of pulmonary arterial hypertension (PAH)
#210INHALED IMATINIB FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)
#211INHALABLE CANNABINOID COMPOSITIONS AND USES
#212CRYSTAL FORM OF SESQUITERPENE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
#213Composition for inhalation
#214RIBAVIRIN PERFLUBRON EMULSION COMPOSITION FOR TREATING VIRAL DISEASES
#215Conformal coating of cells for immunoisolation
#216Antiarrhythmic formulation
#217Antiarrhythmic formulation
#218Compositions and methods of making brittle-matrix particles through blister pack freezing
#219Aerosol formulation for COPD
#220Porous particle and method for producing the same, and pharmaceutical composition
#221Medicament for prevention of treatment of rhinovirus infection
#222LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#223Meta tyrosine derivatives as rho-kinase inhibitors
#224Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#225Unit aerosol doses for anticoagulation
#226Genotype-agnostic rescue of cystic fibrosis with small molecule bicarbonate channels
#227INHALABLE COMPOSITION OF CLOFAZIMINE AND METHODS OF USE THEREOF
#228Intranasally administered antihistamines and uses thereof
#229COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS USING SAME
#230Buccal, sublingual and intranasal delivery of fospropofol
#231Pharmaceutical composition
#232Pharmaceutical composition
#233METHODS OF TREATMENT OF RESPIRATORY DISORDERS
#234NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF
#235INTRANASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION
#236METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION
#237MDI RELATED PRODUCTS AND METHODS OF USE
#238Methods and compositions for treating mucosal tissue disorders
#239MICROORGANISMS FOR USE AND DELIVERY TO THE RESPIRATORY SYSTEM
#240COMPOSITIONS COMPRISING SALBUTAMOL SULPHATE
#241UNIT DOSES, AEROSOLS, KITS, AND METHODS FOR TREATING HEART CONDITIONS BY PULMONARY ADMINISTRATION
#242UNIT DOSES, AEROSOLS, KITS, AND METHODS FOR TREATING HEART CONDITIONS BY PULMONARY ADMINISTRATION
#243Treprostinil administration by inhalation
#244CANNABINOID COMPOSITIONS AND USES
#245PROMOTING LUNG GROWTH
#246Lipo-glycopeptide cleavable derivatives and uses thereof
#247Cromolyn Compositions for Treatment of Chronic Cough Due to Idiopathic Pulmonary Fibrosis
#248CANNABINOID COMPOSITIONS AND USES
#249CRYSTALLINE MICROPARTICLES OF A BETA-AGONIST COATED WITH A FATTY ACID
#250Atropisomerism for increased kinase inhibitor selectivity
#251Methods of treatment using a JAK inhibitor compound
#252Methods for treatment of pulmonary hypertension
#253NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#254SAFER AND MORE EFFECTIVE METHODS OF TRANSMUCOSAL, INCLUDING INTRANASAL, DELIVERY FOR RAISING BLOOD PRESSURE AND STIMULATING THE BODY
#255Pharmaceutical solution formulations for pressurized metered dose inhalers
#256Pharmaceutical composition
#257Compositions and methods of making brittle-matrix particles through blister pack freezing
#258PHARMACEUTICAL COMPOSITION
#259PHARMACEUTICAL COMPOSITION
#260Pharmaceutical composition
#261Pharmaceutical composition
#262SUBSTITUTED 4-METHYL-PYRROLO[1,2-A]PYRIMIDINE-8-CARBOXAMIDE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY
#263Pharmaceutical composition
#264Delivery Of Esketamine For The Treatment Of Depression
#265PHARMACEUTICAL COMPOSITION
#266High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
#267PHARMACEUTICAL COMPOSITION
#268PHARMACEUTICAL COMPOSITION
#269Emollient topical disinfectants
#270Intranasal administration of physiologically active substances
#271Peptide inhibition of CCR3-mediated diseases or conditions
#272Pharmaceutical composition
#273PHARMACEUTICAL COMPOSITION
#274TREPROSTINIL ADMINISTRATION BY INHALATION
#275Cannabinoid compositions and uses
#276COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
#277Methods of treatment using a JAK inhibitor compound
#278Dry powder compositions with magnesium stearate
#279Inhaled aspirin and magnesium to treat inflammation
#2803,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS
#281Compositions for pulmonary delivery of long-acting muscarinic antagonists or long-acting B2 adrenergic receptor agonists and associated methods and systems
#282USE OF CICLESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES
#283Pharmaceutical composition
#284Recombinant lubricin
#285Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
#286Compositions and methods for administration of an enzyme to a subject's airway
#287Pharmaceutical composition
#288Pharmaceutical composition
#289Selective bromodomain inhibition of fungal Bdf1
#290COMPOSITIONS AND METHODS FOR TREATMENT OF COPD
#291Composition for Inhalation
#292Particles with RNA cleaving nucleobase polymers and uses for managing inflammatory disorders
#293Pheromone compositions for stimulating early onset of estrus and reducing labor needs in breeding peri-pubertal suids and methods of use
#294Method of preparing a pharmaceutical composition
#295PARTICULATE MATERIALS
#296Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
#297Substituted 4-methyl-pyrrolo[1,2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
#298Pharmaceutical compositions
#299Metered dose inhaler training device
#300Powder formulation